Horizon Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-07-2024
- Paid Up Capital ₹ 1.00 M
as on 02-07-2024
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 63.67 M
as on 02-07-2024
- Revenue 150.78%
(FY 2022)
- Profit 145.24%
(FY 2022)
- Ebitda 71.30%
(FY 2022)
- Net Worth 209.04%
(FY 2022)
- Total Assets 6.78%
(FY 2022)
About Horizon Biosciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹6.37 Cr.
Gaurav Rastogi, Leena Rastogi, Alpana Rastogi, and One other member serve as directors at the Company.
- CIN/LLPIN
U33110HR2010PTC041091
- Company No.
041091
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Horizon Biosciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Rastogi  | Director | 20-Aug-2010 | Current |
| Leena Rastogi | Additional Director | 21-Mar-2016 | Current |
| Alpana Rastogi | Additional Director | 21-Mar-2016 | Current |
| Tarun Rastogi | Director | 20-Aug-2010 | Current |
Financial Performance and Corporate Structure Insights of Horizon Biosciences.
Horizon Biosciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 150.78% increase. The company also saw a substantial improvement in profitability, with a 145.24% increase in profit. The company's net worth Soared by an impressive increase of 209.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Horizon Biosciences?
In 2022, Horizon Biosciences had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rgr Trading Private Limited
Active
18 years 4 months Gaurav Rastogi and Tarun Rastogi are mutual person
Horizon Infraventures Private Limited
Active 13 years 5 months Gaurav Rastogi and Tarun Rastogi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 23 May 2023 | ₹2.40 M | Open |
Yes Bank Limited Creation Date: 30 Mar 2018 | ₹4.23 Cr | Open |
Vijaya Bank Creation Date: 30 Sep 2016 | ₹1.90 Cr | Open |
How Many Employees Work at Horizon Biosciences?
Unlock and access historical data on people associated with Horizon Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Mar 04, 2016, Horizon Biosciences has raised a total of ₹ 0.4 M, with the most recent deal valued at ₹ 0.2 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
